ArticleFrontiers in bioengineering and biotechnology2023

Sustained release of a highly specific GSK3β inhibitor SB216763 in the PCL scaffold creates an osteogenic niche for osteogenesis, anti-adipogenesis, and potential angiogenesis.

Weimin Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.